CAS: 90409-78-2; 4-[3-(4-Carboxyphenoxy)Propoxy]Benzoic Acid,Decanedioic Acid

该化合物是属于聚酰胺类的合成聚合物,其独特结构包括重复体,有助于其热塑性特性,这种聚合物具有良好的热稳定性和机械强度,适合各种应用,包括在医疗领域,特别是在药物运载系统和作为生物材料.Polifeprosan具有生物兼容性,这意味着它可以安全地与生物系统互动,并经常用于植入器和其他医疗装置的配制.此外,它可以加工成不同的形式,例如胶片或纤维,允许其应用的多功能.其化学稳定性和在生理条件下降解的耐性,进一步提高了其长期应用的效用.

英文名称4-[3-(4-Carboxyphenoxy)Propoxy]Benzoic Acid,Decanedioic Acid
中文名称聚苯丙生
其它别名Benzoicacid, 4,4'-[1,3-propanediylbis(oxy)]bis-, polymer with decanedioic acid (9CI); 1,3-Bis(p-carboxyphenoxy)propane-sebacic acid copolymer; Biodel; Bis(1,3-carboxyphenoxy)propane-sebacic acid copolymer; Polifeprosan; Polifeprosan20
CAS编号90409-78-2
MFCD编号:MFCD00867829
分子式:C27H34O10分子量:518.56
产品CID: 1936914
产品分类有机原料 → 脂质和类脂质分子 → 脂肪酰基

相似结构搜索
产品信息参考;
InChIKey: JVYNJRBSXBYXQB-UHFFFAOYSA-N
1S/C17H16O6.C10H18O4/c18-16(19)12-2-6-14(7-3-12)22-10-1-11-23-15-8-4-13(5-9-15)17(20)21;11-9(12)7-5-3-1-2-4-6-8-10(13)14/h2-9H,1,10-11H2,(H,18,19)(H,20,21);1-8H2,(H,11,12
计算化学: 氢键受体数10.0氢键供体数4.0可旋转键数17.0

MSDS等安全信息

合成工艺路线路线简述

海关参考信息

2905121000-正丙醇
2905130000-正丁醇
2905399001-1,3-丙二醇
2906210000-苄醇
💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
详情请参考：📖 海关编码查询和海关进出口税则

专利信息

专利号:US-2018312534-A1
优先权日:2015-10-16
标题:Fluorescent anticancer platinum drugs
发明人：SARKAR ARINDAM; MANDAL SWADHIN KUMAR; SENGUPTA ANIRUDDHA; BISWAS GOUTAM; DUTTA PRADIP; SHARMA RUPALI; RAJ JUSTIN PAUL; SURYAVANSHI HEMANT; KUMARI SMITA
权利人:INVICTUS ONCOLOGY PVT LTD
摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to fluorescent platinum based compounds. The disclosure further relates to synthesis of said fluorescent platinum based compounds, nanoparticles and compositions comprising said fluorescent platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by the fluorescence changes between aforesaid platinum based compounds and corresponding free ligands, nanoparticles and compositions.

专利号:US-10730899-B2
优先权日:2013-06-14
标题 :Lipid-based platinum compounds and nanoparticles
发明人：SENGUPTA SHILADITYA; ROY MONIDEEPA; SARKAR ARINDAM; HOSSAIN SK SAMAD; SENGUPTA ANIRUDDHA; DUTTA PRADIP; ANSARI AASIF
权利人:AKAMARA THERAPEUTICS INC
摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based compounds comprising platinum moiety, linker moiety and lipid moiety and corresponding nanoparticles thereof. The disclosure further relates to synthesis of said platinum based compounds, nanoparticles and compositions comprising said platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by employing aforesaid carbene compounds, platinum based compounds, nanoparticles and compositions thereof.